(Q43923080)

28 November 2017

title

Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood (English)

1 reference

28 November 2017

1 reference

Dario A

1

1 reference

28 November 2017

Di Stefano MG

2

1 reference

28 November 2017

Grossi A

3

1 reference

28 November 2017

Casagrande F

4

1 reference

28 November 2017

Bono G

5

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Acta Neurologica Scandinavica

28 November 2017

published in

1 reference

28 November 2017

volume

105

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

83-87

1 reference

Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Treatment of cerebral origin spasticity with continuous intrathecal baclofen delivered via an implantable pump: long-term follow-up review of 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Assessment of outcome after severe brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

Management of Intractable Spasticity of Supraspinal Origin by Chronic Cervical Intrathecal Infusion of Baclofen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

Cost analysis of continuous intrathecal baclofen versus selective functional posterior rhizotomy in the treatment of spastic quadriplegia associated with cerebral palsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.1O042.X

7 January 2021

10.1034/J.1600-0404.2002.1O042.X

Identifiers

DOI

1 reference

28 November 2017

1 reference